Arvinas, Inc. (ARVN)
NASDAQ: ARVN · Real-Time Price · USD
7.67
0.00 (0.00%)
At close: Jun 18, 2026, 4:00 PM EDT
7.52
-0.15 (-1.96%)
After-hours: Jun 18, 2026, 5:52 PM EDT
Arvinas Market Cap
Arvinas has a market cap or net worth of $494.88 million as of June 18, 2026. Its market cap has decreased by -2.45% in one year.
Market Cap
494.88M
Enterprise Value
-111.62M
1-Year Change
-2.45%
Ranking
Category
Stock Price
$7.67
Market Cap Chart
Since September 27, 2018, Arvinas's market cap has decreased from $516.15M to $494.88M, a decrease of -4.12%. That is a compound annual growth rate of -0.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 494.88M | -35.03% |
| Dec 31, 2025 | 761.70M | -42.17% |
| Dec 31, 2024 | 1.32B | -52.94% |
| Dec 29, 2023 | 2.80B | 53.71% |
| Dec 30, 2022 | 1.82B | -58.07% |
| Dec 31, 2021 | 4.34B | 6.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Altimmune | 513.41M |
| Valneva SE | 511.98M |
| Indaptus Therapeutics | 509.59M |
| Rezolute | 500.40M |
| AgomAb Therapeutics NV | 497.65M |
| 4D Molecular Therapeutics | 492.44M |
| Kyverna Therapeutics | 486.66M |
| Neurogene | 486.54M |